1Cloherty JP,Eichenwald EC,Stark AR,et al.Manual of neonatal care.6th ed.Lippicott Williams&Wilkins,2008.388-435,562.
2Hoffman JI,Kaplan S.The incidence of congenital heart disease.J Am Coll Cardiol,2002,39:1890-1900.
3Shultz AH,Localio AR,Clark BJ,et al.Epidemiologic features of the presentation of critical congenital heart disease:implication for screening.Pediatrics,2008,121:751-757.
4Chen Q,Parry AJ. The current role of hybrid procedures in the stage 1 palliation of patients with hypoplastic left heart syndrome. Eur J Cardiothorac Surg, 2009,36:77-83.
5Galantowicz M, Cheatham JP, Phillips A, et al. Hybrid approach for hypoplastic left heart syndrome: intermediate results after the learning curve. Ann Thorac Surg, 2008,85:2063-2070.
6Shah PS, Ohlsson A. Sildenafil for pulmonary hypertension in neonates. Cochrane Database Syst Rev, 2007,18 : CD005494.
7Baquero H,Soliz A, Neira F,et al. Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Pediatrics, 2006,117 : 1077-1083.
8Verheijen PM, Lisowski LA, Stoutenbeek P, et al. Prenatal diagnosis of congenital heart disease affects preoperative acidosis in the newborn patient[ J]. J Thorac Cardiovasc Surg ,2001,121 (4) :798 - 803.
9Kovalchin JP,Silverman NH. The impact of fetal echocardiography[ J]. Pediatr Cardiol, 2004,25 (3) : 299 - 306.
10Meberg A, Lindberg H,Thaulow E. Congenital heart defects:The patients who die[ J]. Acta Pediatr,2005,94( 8 ) :1060 -1065.
